tiprankstipranks
Zoetis CEO says Librela U.S. Street estimate ‘not unreasonable’
PremiumThe FlyZoetis CEO says Librela U.S. Street estimate ‘not unreasonable’
2M ago
Zoetis price target lowered to $225 from $230 at HSBC
PremiumThe Fly
Zoetis price target lowered to $225 from $230 at HSBC
2M ago
Zoetis lowers FY24 adjusted EPS view to $5.71-$5.81 from $5.74-$5.84
PremiumThe Fly
Zoetis lowers FY24 adjusted EPS view to $5.71-$5.81 from $5.74-$5.84
3M ago
Zoetis price target lowered to $200 from $205 at BofA
PremiumThe FlyZoetis price target lowered to $200 from $205 at BofA
3M ago
Zoetis to sell medicated feed additive portfolio to Phibro Animal Health
PremiumThe Fly
Zoetis to sell medicated feed additive portfolio to Phibro Animal Health
3M ago
Zoetis price target lowered to $230 from $260 at Barclays
PremiumThe Fly
Zoetis price target lowered to $230 from $260 at Barclays
3M ago
Zoetis price target lowered to $195 from $220 at Piper Sandler
PremiumThe FlyZoetis price target lowered to $195 from $220 at Piper Sandler
3M ago
WSJ Zoetis article does not bring new information, says William Blair
PremiumThe Fly
WSJ Zoetis article does not bring new information, says William Blair
3M ago
WSJ article highlights known debates on safety of Zoetis’ Librela, says BofA
PremiumThe Fly
WSJ article highlights known debates on safety of Zoetis’ Librela, says BofA
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100